Enhancing case managers' skills in the assessment and management of antipsychotic medication side-effects

References

• Chen A. Non‐compliance in community psychiatry: a review of clinical interventions. Hospital and Community Psychiatry 1991; 42: 282–287
   PubMedGoogle Scholar
• Hirsch S, Bowen J, Emami J, et al. A one year prospective study of the effects of life events and medication in the aetiology of schizophrenic relapse. British Journal of Psychiatry 1996; 168: 49–56
   PubMed Web of Science ®Google Scholar
• Keks N. Minimising the non‐extrapyramidial side‐effects of antipsychotics. Acta Psychiatrica Scandinavica 1996; 94: 18–24
   PubMed Web of Science ®Google Scholar
• Finn SE, Bailey JM, Schultz RT, Faber R. Subjective utility ratings of neuroleptics in treating schizophrenia. Psychological Medicine 1990; 20: 843–848
   PubMed Web of Science ®Google Scholar
• Michaels RA, Mumford K. Identifying akinesia and akathisia: the relationship between patient's self‐report and nurse's assessment. Archives of Psychiatric Nursing 1989; 3: 97–101
   PubMedGoogle Scholar
• Littrell KH. Beyond compliance: evaluating antipsychotic efficacy. Journal of the American Psychiatric Nurses Association 1996; 2: 186–190
   Google Scholar
• Wade T, Weir D. Consumer, carer and prescriber strategies to enhance consumer compliance with psychotropic medication for severe mental illness. Commonwealth Department of Human Services and Health, Canberra 1995
   Google Scholar
• Brown CS, Wright RG, Christensen DB. Association between type of medication instruction and patients knowledge, side effects, and compliance. Hospital and Community Psychiatry 1987; 38: 55–60
   PubMedGoogle Scholar
• Clary C, Dever A, Schweizer E. Psychiatric inpatients' knowledge of medication at hospital discharge. Hospital and Community Psychiatry 1992; 43: 140–144
   PubMedGoogle Scholar
• Lund VE, Frank DI. Helping the medicine go down. Journal of Psychosocial Nursing 1991; 29: 6–9
   PubMedGoogle Scholar
• Davidhizar RE. Can clients with schizophrenia describe feelings and beliefs about taking medications?. Journal of Advanced Nursing 1985; 10: 469–473
   PubMedGoogle Scholar
• Del Compo EJH, Carr CF, Correa E. Rehospitalised schizophrenics. What they report about illness, treatment and compliance. Journal of Psychosocial Nursing and Mental Health Services 1983; 21: 29–33
   Google Scholar
• Bebbington PE. The content and context of compliance. [Abstract]. Internatinal Clinincal Psychopharmacology 1995; 9(Suppl. 5)41–50
   PubMed Web of Science ®Google Scholar
• Green JH. Frequent rehospitalization and non‐compliance with treatment. Hospital and Community Psychiatry 1988; 39: 963–966
   PubMedGoogle Scholar
• Donovan JL, Blake DR. Patient non‐compliance: deviance or reasoned decision‐making? [Abstract]. Social Science and Medicine 1992; 34: 507–513
   PubMed Web of Science ®Google Scholar
• Home R. Representations of medication and treatment: advances in theory and measurement. Perceptions of health and illness. Current research and applications, KJ Petrie, JA Weinman. Harwood, London 1997; 155–188
   Google Scholar
• Bennett J. Drugs and the CPN. Nursing Times 1991; 44: 38–40
   Google Scholar
• Bennett J, Done J, Hunt B. Assessing the side effects of antipsychotic drugs: a survey of CPN practice. Journal of Psychiatric and Mental Health Nursing 1995; 2: 177–182
   PubMedGoogle Scholar
• Bennett J, Done J, Harrison‐Read P, Hunt B. Development of a rating scale/checklist to assess the side effects of antipsychotics by community psychiatric nurses. Community psychiatric nursing. A research perspective, C Brooker, E White. Chapman and Hall, London 1995; vol. 3
   Google Scholar
• Ryan P, Ford R, Clifford P. Case management and community care. Research and Development for Psychiatry, London 1991
   Google Scholar
• Driscoll PL. Maintenance Medication for Chronic Schizophrenics. Risk/Benefit Assessment. Perspectives in Psychiatric Care 1985; 24: 104–110
   Google Scholar
• Kopala LC. Spontaneous and drug‐induced movement disorders in schizophrenia. Acta Psychiatrica Scandinavica 1996; 94: 12–17
   Google Scholar
• Gardiner‐Caldwell Communications. Extrapyramidal symptoms: current concepts and future prospects. Gardiner‐Caldwell, MacclesfieldUK 1993
   Google Scholar
• Gray R, Howard A. The Maudsley medication review clinic. Journal of Psychiatric and Mental Health Nursing 1997; 4: 225–226
   PubMedGoogle Scholar
• PHARM. Pharmaceutical Health And Rational Use of Medicines Committee Consumer Taskforce. A script for change: a consumer perspective on the quality use of medicines. Commonwealth Department of Health and Family Services, Canberra 1995
   Google Scholar
• Rudman MJ. User involvement in mental health nursing practice: rhetoric or reality?. Journal of Psychiatric and Mental Health Nursing 1996; 3: 385–390
   PubMedGoogle Scholar
• Morrison P, Gaskill D, Meehan T, Collings P. Community Nursing Assessments of the Side‐Effects of Antipsychotic Medication. Pharmaceutical Benefits Branch of the Commonwealth Department of Health and Family Services, Canberra 1998, Final report to the
   Google Scholar
• Day JC, Wood G, Dewey M, Bentall R. A self‐rating scale for measuring neuroleptic side‐effects. Validation in a group of schizophrenic patients. British Journal of Psychiatry 1995; 166: 650–653
   PubMed Web of Science ®Google Scholar
• Day JC, Kinderman P, Bentall RP. A comparison of patients' and prescribers' beliefs about neuroleptic side‐effects: prevalence, distress and causation. Acta Psychiatrica Scandinavica 1998; 97: 93–97
   PubMed Web of Science ®Google Scholar
• Awad AG. Subjective response to neuroleptics in schizophrenia. Schizophrenia Bulletin 1993; 19: 609–618
   PubMed Web of Science ®Google Scholar
• Bezchlibnyk‐Butler KZ, Jeffries JJ. Clinical handbook of psychotropic drugs6th edn. Hogrefe and Huber, Toronto 1996
   Google Scholar
• Tugg LA, Desai D, Prendergast P, Remington G, Reed K, Zipursky RB. Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects. Schizophrenia Research 1997; 25: 71–78
   PubMedGoogle Scholar
• Victorian Medical Postgraduate Foundation Therapeutics Committee. Psychotropic drug guidelines3rd edn. Victorian Medical Postgraduate Foundation Therapeutics Committee, Melbourne 1995
   Google Scholar
• Jablensky A, McGrath J, Herrman H, et al. People Living with Psychotic Illness: an Australian Study 1997–98. Commonwealth Department of Health and Aged Care, Canberra 1999
   Google Scholar
• Sane Australia. Antipsychotic medications education project. Department of Health and Family Services, Pharmaceuticals Benefits Branch, Canberra 1997, Final report to the
   Google Scholar
• Weiden PJ, Scheifler PL, Diamond RJ, Ross R. Breakthroughs in antipsychotic medications. A guide for consumers, families, and clinicians. Norton, New York 1999
   Google Scholar